Human T cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus that has
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …

Human T-cell leukemia virus type 1 (HTLV-1) infects mainly CD4+ CCR4+ effector/memory T
cells in vivo. However, it remains unknown whether HTLV-1 preferentially infects these T …

Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus that is the causative agent of
adult T cell leukemia/lymphoma (ATL) and associated with multiorgan inflammatory …

Human T-cell leukemia virus type 1 (HTLV-1) is a complex retrovirus that may have been
transmitted to humans from monkeys more than ten thousands years ago. 1 The human host …

It has been nearly 40 years since human T-cell leukemia virus-1 (HTLV-1), the first
oncogenic retrovirus in humans and the first demonstrable cause of cancer by an infectious …

Human T-lymphotropic virus (HTLV-1) is an ancient pathogen for human being but arising
and recognized recently. The routes of transmission are vertical (mainly by breastfeeding) …

Human T-cell leukemia virus type 1 (HTLV-1), a retrovirus which mainly infects CD4+ T cells
and causes adult T-cell leukemia/lymphoma (ATL), is primarily transmitted via direct cell-to …

HTLV-1 is the causative agent of adult T-cell leukemia/lymphoma (ATLL)(Hinuma et al.,
1981; Miyoshi et al., 1981; Poiesz et al., 1980; Tsukasaki et al., 2004; Yoshida et al., 1984) …

The human retrovirus human T-lymphotropic virus type 1 (HTLV-1) is associated with two
distinct types of disease: the malignancy known as adult T-cell leukemia and a range of …

Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia (ATL) and HTLV-
1-associated myelopathy/tropical spastic paraparesis in small subsets of HTLV-1 carriers …